Type your drug name (like Atorvastatin, Sildenafil, etc)
Cancel
Advertisement
Farxiga Coupon - Farxiga 10mg tablet
FarxigaDapagliflozin
DAPAGLIFLOZIN helps to treat type 2 diabetes. It helps to control blood sugar. Treatment is combined with diet and exercise. The lowest GoodRx price for the most common version of Farxiga is around $469.84, 17% off the average retail price of $568.08. Compare SGLT2 inhibitors.
Prescription Settings
brand
tablet
10mg
30 tablets
Farxiga Coupon - Farxiga 10mg tablet
Farxiga(brand)
tablet
10mg
30 tablets

Farxiga Latest News

Get the latest updates on this drug from the GoodRx medical team

FDA Warns of Serious Genital Infection Linked to SGLT2 Inhibitors for Diabetes

Roni Shye
Roni Shye -

Just last week, the Food and Drug Administration (FDA) released a new warning for SGLT2 inhibitors, a class of drugs used to lower blood sugar in adults with type 2 diabetes. According to the FDA, a serious bacterial infection known as necrotizing fasciitis has been reported in the genital area of some patients taking SGLT2 inhibitors. While this condition is rare and only 12 cases have been confirmed since 2013, necrotizing fasciitis spreads rapidly and can be deadly. See More

The FDA is Currently Reviewing the First Oral Medication for Type 1 Diabetes

Roni Shye
Roni Shye -

After decades of little innovation in treatments for type 1 diabetes, the FDA is on track to approve Zynquista, the first oral antidiabetic drug in the US for adults with type 1 diabetes, by March 2019.

Current type 1 diabetes medications

At present, those with type 1 diabetes, also known as juvenile or insulin-dependent diabetes, use injectable or inhaled insulins to survive. Sometimes, they also use Symlin, an injectable non-insulin drug that makes patients feel full at meals, slows the rate at which food moves from the stomach into the small intestine, and stops the release of glucagon, a hormone that tells the liver to release sugar into the bloodstream. See More

Here Are the 5 Best Ways To Save on Invokana, the Diabetes Drug

Tori Marsh
Tori Marsh -

Let’s start with the bad news. Invokana, a tablet taken to treat type 2 diabetes, is really expensive. A 30-day supply of Invokana can cost around $550, and we may have to wait another six years to see a generic. But there is good news — there are ways to save.

Here’s all the information you need to make your Invokana prescription affordable.

How popular is Invokana?

Approved in 2013, Invokana is one of the most popular SGLT2 inhibitors, a class of drugs that is used to treat diabetes type 2 by blocking the kidneys from reabsorbing glucose so any excess is excreted from the body. See More

Updated FDA Safety Alert: Invokana and Invokamet for Diabetes

Roni Shye
Roni Shye -

On May 16th, 2017, the FDA issued an update on canagliflozin-containing medications, like Invokana and Invokamet, as part of a year-long ongoing review.

This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with canagliflozin than in patients who were given a placebo sugar pill. See More

FDA Approves Qtern for Diabetes

Roni Shye
Roni Shye -

According to The American Diabetes Association, as of 2012, type 2 diabetes affected 29.1 million Americans, 9.3% of the population. Every year another 1.4 million Americans are diagnosed with type 2 diabetes, which can lead to live-threatening complications like high-blood pressure, kidney disease, high cholesterol, or loss of vision.

Recently, the FDA approved Qtern (dapagliflozin and saxagliptin), a new combination prescription medication for adults with type 2 diabetes. See More

New FDA Safety Alert: Invokana and Farxiga for Diabetes

Roni Shye
Roni Shye -

In June 2016, the FDA issued a safety alert for canagliflozin (Invokana, Invokamet), used to treat type 2 diabetes.

Now, another warning has been issued, for Invokana and Invokamet along with another similar diabetes medication, dapagliflozin (Farxiga and Xigduo XR).

According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More

Ketoacidosis Warning Issued for New Diabetes Meds

Roni Shye
Roni Shye -

On May 15, 2015, the FDA issued a warning for the newest class of diabetes medications, SGLT2 inhibitors.

According to the FDA, the medications in this class may lead to a serious and life-threatening condition known as ketoacidosis.

Which medications are considered SGLT2 inhibitors?

These medications also contain SGLT2 inhibitors in combination with other active ingredients:

What should I do if I am taking one of these medications?

If you are taking one of the medications listed above DO NOT stop your medication without talking to your doctor. See More

40+ Brand-Name Drugs Dropped By Insurance in 2015

Elizabeth Davis
Elizabeth Davis -

For many Americans with health insurance, more than 40 popular brand-name drugs may no longer be covered starting in January 2015. Express Scripts and Caremark, companies that handle pharmacy benefits for more than 200 million Americans, are removing over 40 drugs from their formularies at the end of 2014. This is in addition to the more than 50 drugs removed last year.

What are Express Scripts and Caremark?

Express Scripts and Caremark are companies that administer prescription drug benefits for many health insurance companies and Tricare. See More

New Diabetes Treatment Approved: Jardiance

Roni Shye
Roni Shye -

Jardiance (empagliflozin) was approved by the FDA on August 1, 2014 for the treatment of type 2 diabetes.

What type of medication is Jardiance?
Jardiance is part of a new class of medications recently approved by the FDA, Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors.

How does Jardiance work?

It works with the body’s natural process of urination to help remove more excess sugar from the body rather than allowing it to be reabsorbed by your kidneys. See More

What?! Another New Medication for Diabetes?

Dr. Sharon Orrange
Dr. Sharon Orrange -

With 25 million Americans with adult-onset diabetes I guess it’s great we have so many new medications coming down the pipeline. As a primary care doctor, even my head is spinning learning the details of the newest diabetes medications but it’s exciting . . . and here is another one.

Remember, all guidelines agree that for most folks metformin is the first line diabetes medication, and it’s cheap and easy. See More

Copyright ©2018 GoodRx, Inc.
GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
LegitScript SealNABP SealBBB Seal